ProSomnus receives FDA clearance for sleep apnea monitoring device

April 13, 2026 6:02 AM EDT Send to a Friend
ProSomnus Sleep Technologies announced that the U.S. Food and Drug Administration has granted Class II 510(k) clearance for its RPMO₂ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login